| Geld/Brief | 42,55 $ / 42,66 $ |
| Spread | +0,26% |
| Schluss Vortag | 40,21 $ |
| Gehandelte Stücke | 59.112 |
| Tagesvolumen Vortag | 1.673.063 $ |
| Tagestief 41,20 $ Tageshoch 43,28 $ | |
| 52W-Tief 13,64 $ 52W-Hoch 43,65 $ | |
| Jahrestief 25,28 $ Jahreshoch 43,65 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -125,10 $ |
| Jahresüberschuss in Mio. | -111,48 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -2,37 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -21,76% |
| Marktkapitalisierung in Mio. | 1.919 $ |
| KGV (Kurs/Gewinn) | -12,80 |
| KBV (Kurs/Buchwert) | 2,94 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +94,58% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 40,67 $ | 0 % | 40,67 $ | 20.07.26 | |
| Nasdaq | 42,625 $ | +6,01% | 40,21 $ | 21:59 | |
| NYSE | 42,62 $ | +5,26% | 40,49 $ | 21:59 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 20.07.26 | 40,28 | 1,67 M |
| 17.07.26 | 42,62 | 5,55 M |
| 16.07.26 | 40,13 | 4,89 M |
| 15.07.26 | 39,93 | 1,11 M |
| 14.07.26 | 41,46 | 1,55 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 41,46 $ | -2,85% |
| 1 Monat | 37,34 $ | +7,87% |
| 6 Monate | 26,40 $ | +52,58% |
| 1 Jahr | 14,39 $ | +179,92% |
| 5 Jahre | - | - |
| Marktkapitalisierung | 1,92 Mrd. $ |
| Streubesitz | 66,45% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +15,00% | FMR Inc |
| +14,92% | TRV GP V, LLC |
| +7,80% | ARCH VENTURE CORP |
| +7,60% | American Funds SMALLCAP World A |
| +6,62% | Fidelity Growth Compy Commingled Pl S |
| +6,48% | Capital Research & Mgmt Co - Division 3 |
| +6,19% | Cormorant Asset Management, LLC |
| +6,15% | The Goldman Sachs Group Inc |
| +5,09% | BlackRock Inc |
| +4,66% | Fidelity Growth Company Fund |
| +3,98% | Sofinnova Ventures |
| +3,80% | Vanguard Group Inc |
| +3,73% | Johnson & Johnson |
| +3,25% | Polar Capital Biotech S Inc |
| +3,24% | Baker Bros Advisors LP |
| +2,77% | Vanguard Capital Management, LLC |
| +2,32% | Vestal Point Capital LP |
| +2,10% | Polar Capital Holdings PLC |
| +2,04% | Vanguard Total Stock Mkt Idx Inv |
| +2,03% | TRV GP VI, LLC |
| +1,92% | UBS Asset Mgmt Americas Inc |
| +1,81% | T. Rowe Price Associates, Inc. |
| +1,59% | State Street Corp |
| +1,52% | AllianceBernstein L.P. |
| +1,51% | Geode Capital Management, LLC |
| +1,48% | Siren, L.L.C. |
| +1,46% | iShares Russell 2000 ETF |
| +1,44% | Fidelity Growth Company K6 |
| +1,41% | Perceptive Advisors LLC |
| +1,33% | T. Rowe Price Health Sciences |
| +1,23% | Fidelity Series Growth Company |
| +0,99% | Fidelity Select Biotechnology |
| +0,76% | T. Rowe Price Small-Cap Value |
| +0,68% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,66% | AB Small Cap Growth A |
| +0,58% | Fidelity Small Cap Index |
| +0,52% | iShares Russell 2000 Value ETF |
| +0,51% | UBS (Lux) EF Biotech (USD) P-acc |
| +0,50% | UBS Lux Dgtl Hlth Eq Fd seeding P acc |
| +0,49% | T. Rowe Price U.S. SC Value Eq Tr-D |
| +0,45% | iShares Biotechnology ETF |
| +0,37% | Russell 2000 Equity Index Fund B |
| +104,18% | Institutionelle Aktionäre |
| +66,45% | Streubesitz |
| -37,73% | Individuelle Aktionäre |
